nodes	percent_of_prediction	percent_of_DWPC	metapath
Lumiracoxib—PTGS2—ovarian follicle—ovarian cancer	0.0865	0.286	CbGeAlD
Lumiracoxib—Tolmetin—CXCL8—ovarian cancer	0.0732	0.593	CrCbGaD
Lumiracoxib—Diclofenac—CXCL8—ovarian cancer	0.0403	0.326	CrCbGaD
Lumiracoxib—PTGS1—oviduct—ovarian cancer	0.0398	0.132	CbGeAlD
Lumiracoxib—PTGS2—myometrium—ovarian cancer	0.0122	0.0402	CbGeAlD
Lumiracoxib—PTGS2—embryo—ovarian cancer	0.0117	0.0387	CbGeAlD
Lumiracoxib—Diclofenac—ABCB1—ovarian cancer	0.01	0.081	CrCbGaD
Lumiracoxib—PTGS1—epithelium—ovarian cancer	0.00999	0.033	CbGeAlD
Lumiracoxib—PTGS1—uterine cervix—ovarian cancer	0.0099	0.0328	CbGeAlD
Lumiracoxib—PTGS2—epithelium—ovarian cancer	0.00955	0.0316	CbGeAlD
Lumiracoxib—CYP2C19—vagina—ovarian cancer	0.00948	0.0314	CbGeAlD
Lumiracoxib—PTGS2—uterine cervix—ovarian cancer	0.00947	0.0313	CbGeAlD
Lumiracoxib—PTGS1—endometrium—ovarian cancer	0.00896	0.0296	CbGeAlD
Lumiracoxib—PTGS2—endometrium—ovarian cancer	0.00856	0.0283	CbGeAlD
Lumiracoxib—PTGS1—uterus—ovarian cancer	0.00825	0.0273	CbGeAlD
Lumiracoxib—CYP2C9—female reproductive system—ovarian cancer	0.00813	0.0269	CbGeAlD
Lumiracoxib—PTGS2—uterus—ovarian cancer	0.00789	0.0261	CbGeAlD
Lumiracoxib—PTGS1—female reproductive system—ovarian cancer	0.00742	0.0245	CbGeAlD
Lumiracoxib—PTGS2—female reproductive system—ovarian cancer	0.00709	0.0235	CbGeAlD
Lumiracoxib—PTGS1—female gonad—ovarian cancer	0.00675	0.0223	CbGeAlD
Lumiracoxib—PTGS1—vagina—ovarian cancer	0.00671	0.0222	CbGeAlD
Lumiracoxib—PTGS2—bone marrow—ovarian cancer	0.0067	0.0221	CbGeAlD
Lumiracoxib—PTGS2—female gonad—ovarian cancer	0.00645	0.0213	CbGeAlD
Lumiracoxib—PTGS2—vagina—ovarian cancer	0.00641	0.0212	CbGeAlD
Lumiracoxib—PTGS1—testis—ovarian cancer	0.00599	0.0198	CbGeAlD
Lumiracoxib—PTGS1—lymph node—ovarian cancer	0.00434	0.0144	CbGeAlD
Lumiracoxib—PTGS2—lymph node—ovarian cancer	0.00415	0.0137	CbGeAlD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	0.00115	0.002	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	0.00112	0.00195	CbGpPWpGaD
Lumiracoxib—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	0.00109	0.00191	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	0.00108	0.00188	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.00108	0.00188	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.00108	0.00188	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CHMP4C—ovarian cancer	0.00105	0.00183	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—NRAS—ovarian cancer	0.00103	0.00179	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—NME2—ovarian cancer	0.00101	0.00175	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CYTB—ovarian cancer	0.001	0.00175	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000981	0.00171	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—CXCL8—ovarian cancer	0.000976	0.0017	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—MYC—ovarian cancer	0.000958	0.00167	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.000954	0.00166	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—CDKN1B—ovarian cancer	0.000954	0.00166	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	0.000953	0.00166	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	0.000942	0.00164	CbGpPWpGaD
Lumiracoxib—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	0.000935	0.00163	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—CASP3—ovarian cancer	0.000935	0.00163	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL2—ovarian cancer	0.000933	0.00163	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000925	0.00161	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000922	0.00161	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—BCL9—ovarian cancer	0.000912	0.00159	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—CCND1—ovarian cancer	0.00091	0.00158	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.000902	0.00157	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—KRAS—ovarian cancer	0.000885	0.00154	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—MMP9—ovarian cancer	0.000883	0.00154	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000878	0.00153	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	0.000877	0.00153	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—BRIP1—ovarian cancer	0.000877	0.00153	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PPP1CC—ovarian cancer	0.000877	0.00153	CbGpPWpGaD
Lumiracoxib—PTGS1—Selenium Micronutrient Network—IL6—ovarian cancer	0.000874	0.00152	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	0.000858	0.00149	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	0.000858	0.00149	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	0.000858	0.00149	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000855	0.00149	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000844	0.00147	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CYTB—ovarian cancer	0.000818	0.00142	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	0.000811	0.00141	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000799	0.00139	CbGpPWpGaD
Lumiracoxib—PTGS2—C-MYB transcription factor network—HRAS—ovarian cancer	0.000752	0.00131	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—MAPK3—ovarian cancer	0.00075	0.00131	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NME2—ovarian cancer	0.000732	0.00127	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—MYC—ovarian cancer	0.00073	0.00127	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000721	0.00126	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—BRIP1—ovarian cancer	0.000715	0.00125	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PPP1CC—ovarian cancer	0.000715	0.00125	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—MAPK1—ovarian cancer	0.000714	0.00124	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—EGFR—ovarian cancer	0.000714	0.00124	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	0.0007	0.00122	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000697	0.00121	CbGpPWpGaD
Lumiracoxib—PTGS2—Selenium Micronutrient Network—IL6—ovarian cancer	0.000694	0.00121	CbGpPWpGaD
Lumiracoxib—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	0.000689	0.0012	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PPP1CC—ovarian cancer	0.000678	0.00118	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NME2—ovarian cancer	0.000667	0.00116	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CYTB—ovarian cancer	0.000649	0.00113	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	0.000649	0.00113	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000639	0.00111	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	0.000636	0.00111	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000635	0.00111	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000621	0.00108	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	0.000619	0.00108	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	0.000613	0.00107	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—TP53—ovarian cancer	0.000599	0.00104	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	0.000597	0.00104	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—YAP1—ovarian cancer	0.000588	0.00102	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000582	0.00101	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NME2—ovarian cancer	0.00057	0.000993	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—BRIP1—ovarian cancer	0.000567	0.000988	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PPP1CC—ovarian cancer	0.000567	0.000988	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000566	0.000986	CbGpPWpGaD
Lumiracoxib—PTGS2—Spinal Cord Injury—IL6—ovarian cancer	0.000548	0.000955	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	0.000539	0.00094	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000521	0.000907	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HDAC6—ovarian cancer	0.000514	0.000894	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000512	0.000891	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	0.00051	0.000889	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000506	0.000881	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	0.000496	0.000865	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	0.000486	0.000846	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	0.000485	0.000846	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000484	0.000842	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—FASN—ovarian cancer	0.000479	0.000835	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—YAP1—ovarian cancer	0.000479	0.000835	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000474	0.000826	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—SLC5A5—ovarian cancer	0.000472	0.000821	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYTB—ovarian cancer	0.000472	0.000821	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000461	0.000804	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000461	0.000803	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	0.000459	0.000799	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—SLC2A1—ovarian cancer	0.000455	0.000793	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000446	0.000777	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—XIAP—ovarian cancer	0.000445	0.000776	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CYP1B1—ovarian cancer	0.000437	0.000761	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—SMARCA4—ovarian cancer	0.000434	0.000756	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYTB—ovarian cancer	0.00043	0.000749	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—EREG—ovarian cancer	0.000423	0.000738	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	0.000421	0.000734	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.00042	0.000732	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000417	0.000727	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000414	0.00072	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PPP1CC—ovarian cancer	0.000412	0.000718	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—BRIP1—ovarian cancer	0.000412	0.000718	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	0.000408	0.00071	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000394	0.000687	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—FASN—ovarian cancer	0.000391	0.000681	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PPP2R1A—ovarian cancer	0.000387	0.000675	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000385	0.000671	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—SLC5A5—ovarian cancer	0.000384	0.00067	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—YAP1—ovarian cancer	0.000381	0.000663	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000377	0.000656	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PPP1CC—ovarian cancer	0.000376	0.000655	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—BRIP1—ovarian cancer	0.000376	0.000655	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—SLC2A1—ovarian cancer	0.000371	0.000647	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—FASN—ovarian cancer	0.00037	0.000645	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PARP1—ovarian cancer	0.000369	0.000643	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYTB—ovarian cancer	0.000367	0.00064	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000364	0.000633	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ABCB1—ovarian cancer	0.00036	0.000626	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000359	0.000625	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CYP1B1—ovarian cancer	0.000356	0.00062	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—TYMS—ovarian cancer	0.000353	0.000615	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—SLC2A1—ovarian cancer	0.000352	0.000613	CbGpPWpGaD
Lumiracoxib—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	0.000344	0.0006	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000331	0.000577	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PPP1CC—ovarian cancer	0.000321	0.000559	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—BRIP1—ovarian cancer	0.000321	0.000559	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PPP2R1A—ovarian cancer	0.000316	0.00055	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000314	0.000547	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—FASN—ovarian cancer	0.00031	0.00054	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—SLC5A5—ovarian cancer	0.000305	0.000532	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.0003	0.000523	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PPP2R1A—ovarian cancer	0.000299	0.000521	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—SLC2A1—ovarian cancer	0.000295	0.000513	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ABCB1—ovarian cancer	0.000293	0.000511	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000289	0.000503	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—TYMS—ovarian cancer	0.000288	0.000501	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CAV1—ovarian cancer	0.000285	0.000496	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CYP1B1—ovarian cancer	0.000283	0.000492	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—YAP1—ovarian cancer	0.000276	0.000481	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000274	0.000477	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000274	0.000477	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	0.000272	0.000474	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PIK3CG—ovarian cancer	0.000259	0.000452	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—YAP1—ovarian cancer	0.000252	0.000439	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PPP2R1A—ovarian cancer	0.000251	0.000437	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000249	0.000434	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000249	0.000434	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.00024	0.000419	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TERT—ovarian cancer	0.000238	0.000414	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000234	0.000408	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ABCB1—ovarian cancer	0.000233	0.000405	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CAV1—ovarian cancer	0.000232	0.000404	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—TYMS—ovarian cancer	0.000229	0.000398	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PIK3CD—ovarian cancer	0.000228	0.000397	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—FASN—ovarian cancer	0.000225	0.000393	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—SLC5A5—ovarian cancer	0.000222	0.000386	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	0.000222	0.000386	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CAV1—ovarian cancer	0.00022	0.000383	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000219	0.000382	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—YAP1—ovarian cancer	0.000215	0.000375	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—SLC2A1—ovarian cancer	0.000214	0.000373	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000213	0.000371	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PIK3CG—ovarian cancer	0.000211	0.000368	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.00021	0.000365	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IL6ST—ovarian cancer	0.000208	0.000363	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—FASN—ovarian cancer	0.000205	0.000358	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP1B1—ovarian cancer	0.000205	0.000357	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SLC5A5—ovarian cancer	0.000202	0.000352	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—APC—ovarian cancer	0.0002	0.000349	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PIK3CB—ovarian cancer	0.000199	0.000346	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SLC2A1—ovarian cancer	0.000195	0.00034	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000191	0.000333	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000187	0.000326	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP1B1—ovarian cancer	0.000187	0.000326	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PIK3CD—ovarian cancer	0.000186	0.000324	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CAV1—ovarian cancer	0.000184	0.000321	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	0.000182	0.000317	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000181	0.000316	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PIK3CD—ovarian cancer	0.000176	0.000307	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	0.000176	0.000306	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—FASN—ovarian cancer	0.000176	0.000306	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SLC5A5—ovarian cancer	0.000173	0.000301	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTEN—ovarian cancer	0.000172	0.000299	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ABCB1—ovarian cancer	0.000169	0.000294	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PIK3CG—ovarian cancer	0.000168	0.000292	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SLC2A1—ovarian cancer	0.000167	0.000291	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—TYMS—ovarian cancer	0.000166	0.000289	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	0.000166	0.000289	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000165	0.000288	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000163	0.000284	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PIK3CB—ovarian cancer	0.000162	0.000282	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP1B1—ovarian cancer	0.00016	0.000279	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—ERBB2—ovarian cancer	0.000156	0.000271	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ABCB1—ovarian cancer	0.000154	0.000268	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MTOR—ovarian cancer	0.000153	0.000267	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PIK3CB—ovarian cancer	0.000153	0.000267	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—TYMS—ovarian cancer	0.000151	0.000264	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PIK3CD—ovarian cancer	0.000147	0.000257	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CDKN1B—ovarian cancer	0.000144	0.000251	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	0.000142	0.000247	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000141	0.000246	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PTEN—ovarian cancer	0.00014	0.000244	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CTNNB1—ovarian cancer	0.000136	0.000237	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CAV1—ovarian cancer	0.000134	0.000233	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PTEN—ovarian cancer	0.000133	0.000231	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ABCB1—ovarian cancer	0.000132	0.000229	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—TYMS—ovarian cancer	0.000129	0.000225	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PIK3CB—ovarian cancer	0.000129	0.000224	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	0.000128	0.000223	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CAV1—ovarian cancer	0.000122	0.000212	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PIK3CG—ovarian cancer	0.000122	0.000212	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PIK3CA—ovarian cancer	0.000121	0.000211	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—STAT3—ovarian cancer	0.000119	0.000207	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NRAS—ovarian cancer	0.000118	0.000206	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	0.000117	0.000203	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MAPK3—ovarian cancer	0.000113	0.000197	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PIK3CG—ovarian cancer	0.000111	0.000193	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PTEN—ovarian cancer	0.000111	0.000193	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MYC—ovarian cancer	0.00011	0.000192	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MAPK1—ovarian cancer	0.000108	0.000188	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—EGFR—ovarian cancer	0.000108	0.000188	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PIK3CD—ovarian cancer	0.000107	0.000187	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CAV1—ovarian cancer	0.000104	0.000182	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—KRAS—ovarian cancer	0.000102	0.000177	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	9.96e-05	0.000173	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—AKT1—ovarian cancer	9.89e-05	0.000172	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PIK3CA—ovarian cancer	9.87e-05	0.000172	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PIK3CD—ovarian cancer	9.77e-05	0.00017	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PIK3CG—ovarian cancer	9.49e-05	0.000165	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PIK3CA—ovarian cancer	9.36e-05	0.000163	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PIK3CB—ovarian cancer	9.34e-05	0.000163	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HRAS—ovarian cancer	8.66e-05	0.000151	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PIK3CB—ovarian cancer	8.51e-05	0.000148	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PIK3CD—ovarian cancer	8.34e-05	0.000145	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IL6—ovarian cancer	8.28e-05	0.000144	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTEN—ovarian cancer	8.07e-05	0.000141	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—AKT1—ovarian cancer	8.06e-05	0.00014	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PIK3CA—ovarian cancer	7.84e-05	0.000136	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—AKT1—ovarian cancer	7.64e-05	0.000133	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTEN—ovarian cancer	7.36e-05	0.000128	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PIK3CB—ovarian cancer	7.27e-05	0.000127	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—AKT1—ovarian cancer	6.4e-05	0.000111	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTEN—ovarian cancer	6.29e-05	0.000109	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PIK3CA—ovarian cancer	5.69e-05	9.91e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PIK3CA—ovarian cancer	5.19e-05	9.04e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—AKT1—ovarian cancer	4.65e-05	8.1e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PIK3CA—ovarian cancer	4.43e-05	7.72e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—AKT1—ovarian cancer	4.24e-05	7.38e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—AKT1—ovarian cancer	3.62e-05	6.31e-05	CbGpPWpGaD
